M Dragunow
M Dragunow
Verified email at
Cited by
Cited by
The use of c-fos as a metabolic marker in neuronal pathway tracing
M Dragunow, R Faull
Journal of neuroscience methods 29 (3), 261-265, 1989
Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors
SS Dominy, C Lynch, F Ermini, M Benedyk, A Marczyk, A Konradi, ...
Science advances 5 (1), eaau3333, 2019
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
M Glass, RLM Faull, M Dragunow
Neuroscience 77 (2), 299-318, 1997
Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension
MA Curtis, M Kam, U Nannmark, MF Anderson, MZ Axell, C Wikkelso, ...
science 315 (5816), 1243-1249, 2007
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective
D Young, PA Lawlor, P Leone, M Dragunow, MJ During
Nature medicine 5 (4), 448-453, 1999
Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system.
P Hughes, M Dragunow
Pharmacological reviews 47 (1), 133-178, 1995
Brain-derived neurotrophic factor is reduced in Alzheimer's disease
B Connor, D Young, Q Yan, RLM Faull, B Synek, M Dragunow
Molecular brain research 49 (1-2), 71-81, 1997
The role of neuronal growth factors in neurodegenerative disorders of the human brain
B Connor, M Dragunow
Brain Research Reviews 27 (1), 1-39, 1998
Kindling stimulation induces c-fos protein(s) in granule cells of the rat dentate gyrus
M Dragunow, HA Robertson
Nature 329 (6138), 441-442, 1987
Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain
MA Curtis, EB Penney, AG Pearson, WMC van Roon-Mom, ...
Proceedings of the National Academy of Sciences 100 (15), 9023-9027, 2003
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in …
M Glass, M Dragunow, RLM Faull
Neuroscience 97 (3), 505-519, 2000
Is CREB a key to neuronal survival?
MR Walton, M Dragunow
Trends in neurosciences 23 (2), 48-53, 2000
A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury
P Gluckman, N Klempt, J Guan, C Mallard, E Sirimanne, M Dragunow, ...
Biochemical and biophysical research communications 182 (2), 593-599, 1992
Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss
EJ Beilharz, CE Williams, M Dragunow, ES Sirimanne, PD Gluckman
Molecular Brain Research 29 (1), 1-14, 1995
Induction and experience-dependent consolidation of stable long-term potentiation lasting months in the hippocampus
WC Abraham, B Logan, JM Greenwood, M Dragunow
Journal of Neuroscience 22 (21), 9626-9634, 2002
Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus
H Parker, M Dragunow, MB Hampton, AJ Kettle, CC Winterbourn
Journal of leukocyte biology 92 (4), 841-849, 2012
In situevidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes
M Dragunow, RLM Faull, P Lawlor, EJ Beilharz, K Singleton, EB Walker, ...
Neuroreport 6 (7), 1053-1057, 1995
D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons
M Dragunow, GS Robertson, RLM Faull, HA Robertson, K Jansen
Neuroscience 37 (2), 287-294, 1990
Correlations between immediate early gene induction and the persistence of long-term potentiation
WC Abraham, SE Mason, J Demmer, JM Williams, CL Richardson, ...
Neuroscience 56 (3), 717-727, 1993
Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain
N Coppieters, BV Dieriks, C Lill, RLM Faull, MA Curtis, M Dragunow
Neurobiology of aging 35 (6), 1334-1344, 2014
The system can't perform the operation now. Try again later.
Articles 1–20